Newsroom
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya
2022-12-23
On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s Intern...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout
2022-11-09
On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...